Hormone Receptor Positive Tumor Recruiting Phase 2 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03809988PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)Treatment